Cover Image
Saved in:

Biologics and biosimilars balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009.

Bibliographic Details
Corporate Author: United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy.
Format: Government Document Online Book
Language:English
Published: Washington : U.S. G.P.O., 2010.
Subjects:
Online Access:ONLINE VERSION
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 01837nam a2200373 a 4500
001 1252634
005 20100713101034.0
006 m d f
007 cr bn|||||||||
008 100601s2010 dcua sb f000 0 eng c
010 |a   
035 |a (OCoLC)635577699 
040 |a GPO  |c GPO  |d MvI 
042 |a pcc 
043 |a n-us--- 
049 |a WWW 
050 1 4 |a KF27  |b .J8568 2009e 
074 |a 1020-C (online) 
088 |a Serial no. 111-73 (United States. Congress. House. Committee on the Judiciary) 
086 0 |a Y 4.J 89/1:111-73 
110 1 |a United States.  |b Congress.  |b House.  |b Committee on the Judiciary.  |b Subcommittee on Courts and Competition Policy. 
245 1 0 |a Biologics and biosimilars  |h [electronic resource] :  |b balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009. 
260 |a Washington :  |b U.S. G.P.O.,  |c 2010. 
300 |a 1 online resource (iv, 252 p.) :  |b ill. 
500 |a Title from title screen (viewed on June 1, 2010). 
504 |a Includes bibliographical references. 
500 |a "Serial no. 111-73." 
650 0 |a Drug development  |x Government policy  |z United States. 
650 0 |a Pharmaceutical biotechnology  |x Government policy  |z United States. 
650 0 |a Pharmaceutical biotechnology  |z United States  |v Patents. 
650 0 |a Biologicals  |x Government policy  |z United States. 
776 0 8 |i Print version:  |a United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy.  |t Biologics and biosimilars :  |b balancing incentives for innovation  |h iv, 252 p.  |w (OCoLC)635495590 
856 4 0 |u http://purl.access.gpo.gov/GPO/LPS122600  |z ONLINE VERSION 
852 0 |b WWW  |h KF27  |i .J8568 2009e